CLINICAL RESEARCH
The T786C Endothelial Nitric Oxide Synthase Genotype Predicts Cardiovascular Mortality in High-Risk Patients
Gian Paolo Rossi, MD*,*,
Giuseppe Maiolino, MD*,
Mario Zanchetta, MD ,
Daniele Sticchi, PhD*,
Luigi Pedon, MD ,
Maurizio Cesari, MD*,
Domenico Montemurro, MD*,
Renzo De Toni, BsD*,
Silvia Zavattiero, PhD* and
Achille C. Pessina, MD, PhD*
* DMCS-Internal Medicine 4
Servizio di Emodinamica and Divisione di Cardiologia Ospedale di Cittadella, University of Padua, Padua, Italy
Manuscript received December 23, 2005;
revised manuscript received April 13, 2006,
accepted May 2, 2006.
* Reprint requests and correspondence: Dr. Gian Paolo Rossi, Clinica Medica 4, University Hospital, via Giustiniani, 2, 35126 Padova, Italy. (Email: gianpaolo.rossi{at}unipd.it).
OBJECTIVES: This study sought to investigate the impact of a common T786C single-nucleotide polymorphism (SNP) in the promoter of the endothelial nitric oxide synthase (eNOS, NOS3) gene on cardiovascular (CV) death in a prospective cohort study.
BACKGROUND: The T786C SNP eNOS gene implies a blunted endothelium-dependent vasodilation in hypertensive patients and was associated with multivessel coronary artery disease in cross-sectional studies, but it remained unsettled whether it carried prognostic information.
METHODS: In consecutive white patients of the GENICA (Genetic and Environmental Factors in Coronary Atherosclerosis) study, who underwent coronary angiography between 1999 and 2001, we determined the incidence of CV death at follow-up. The eNOS T786C and the exon 7 G894T SNPs were determined by melting curve analysis of amplicons from allele-specific fluorescence resonance energy transfer probes. Plasma levels of nitrate/nitrite, nitrotyrosine, and myeloperoxidase were also measured. The Kaplan-Meier and Cox regression analyses were used to assess the impact of SNPs on event-free survival.
RESULTS: Complete follow-up data were obtained in 1,086 (98%) patients. After a median follow-up of 1,296 days (range 4 to 2,057 days), we observed 85 (8.2%) CV deaths. There was a significant impact of the T786C eNOS genotype on CV death-free (p = 0.0102) survival, but no differences in CV death rates across G894T genotypes. The TT individuals, who showed a lower survival, exhibited higher plasma myeloperoxidase (p < 0.0001) and lower levels of nitrotyrosine (p < 0.0001) than CC patients.
CONCLUSIONS: The T786C SNP in the promoter of eNOS bears independent prognostic information and is associated with changes in markers of oxidant stress in high-risk white patients referred for coronary angiography.
|
Abbreviations and Acronyms
| | CV = cardiovascular | | CAD = coronary artery disease | | eNOS = endothelial nitric oxide synthase | | HDL = high-density lipoprotein | | LDL = low-density lipoprotein | | LVEF = left ventricular ejection fraction | | MI = myocardial infarction | | MMP = matrix metalloproteinase | | NO = nitric oxide | | RNS = reactive nitrogen species | | ROS = reactive oxygen species | | SNP = single-nucleotide polymorphism |
|
Related Article
-
Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease: A Multiple-Level Biomarker Strategy
- Malte Kelm
J. Am. Coll. Cardiol. 2006 48: 1175-1176.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
A. Gluba, M. Banach, J. Rysz, G. Piotrowski, W. Fendler, and T. Pietrucha
Is Polymorphism Within eNOS Gene Associated With the Late Onset of Myocardial Infarction? A Pilot Study
Angiology,
October 1, 2009;
60(5):
588 - 595.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Sanz, P. R. Moreno, and V. Fuster
The Year in Atherothrombosis
J. Am. Coll. Cardiol.,
April 24, 2007;
49(16):
1740 - 1749.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Antoniades, D. Tousoulis, and C. Stefanadis
Effects of Endothelial Nitric Oxide Synthase Gene Polymorphisms on Oxidative Stress, Inflammatory Status, and Coronary Atherosclerosis: An Example of a Transient Phenotype
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1226 - 1226.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Tanus-Santos and A. Casella-Filho
Cardiovascular Mortality in High-Risk Patients and T-786C Polymorphism in Promoter Region of the Endothelial Nitric Oxide Synthase Gene
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1225 - 1226.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. P. Rossi and M. Cesari
Reply
J. Am. Coll. Cardiol.,
March 20, 2007;
49(11):
1226 - 1227.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kelm
Significance of Vascular Nitric Oxide Synthase Pathways in Coronary Artery Disease: A Multiple-Level Biomarker Strategy
J. Am. Coll. Cardiol.,
September 19, 2006;
48(6):
1175 - 1176.
[Full Text]
[PDF]
|
 |
|
|